Psyence Biomedical Trading Update
Trading Session
- The Psyence Biomedical (PBM) share price increased by 6.6 % during the 24‑hour period ending at 03:20 PM Central Europe on Friday 23 April 2026.
- Current price: USD 4.12 per share on major exchanges.
Market Metrics
- Shares outstanding: 3.8 million.
- Market capitalization: USD 17.2 million.
- Volume traded in the last 24 hours: USD 166.3 thousand.
- 200‑day simple moving average: USD 5.14.
- 52‑week high: USD 132.81 (10 October 2025).
- 52‑week low: USD 1.92 (23 February 2026).
Recent Performance
- Since the end of the previous month, the share price has fallen by 25.9 %.
Comparative Performance of Related Stocks
| Symbol | Last 24‑hour Move | Current Price | Market Capitalization |
|---|---|---|---|
| HOT‑UN.TO (American Hotel Income Proper) | Down 1.82 % | CAD 0.54 | CAD 28.7 million |
| CJR‑B.TO (Corus Entertainment) | Up 4 % | CAD 1.06 | CAD 28.4 million |
| BAU.V (Blue Star Gold) | Down 6.25 % | CAD 0.15 | CAD 28.5 million |
| LME.V (Laurion Mineral Exploration) | Down 3.57 % | CAD 0.14 | CAD 29 million |
| KING.CN (King Global Critical Minerals) | Down 2.22 % | CAD 0.44 | CAD 29 million |
Upcoming Event: Hot Chili Limited Annual General Meeting
- Date: 25 November 2026
- Purpose: Review financial statements, directors’ report, and auditor’s report for the year ended 30 June 2026.
- Key Resolutions:
- Adoption of the remuneration report.
- Re‑election of the board of directors.
- Re‑appointment of the auditor.
- Approval of a new employee incentive plan.
- Grant of short‑term and long‑term performance rights to Managing Director Christian Easterday.
- Approval of issuance of placement shares under listing rules, which will increase the share count.
- Shareholder Interaction: Shareholders will have the opportunity to ask questions of the board and auditors regarding the matters above.
Company Profile
Psyence Biomedical Ltd.
- A Canadian biotechnology company.
- Listed on the Nasdaq stock exchange.
